Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography

计划入组 10 人 · 首次发布于 2015 年 5 月 7 日

Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography

计划入组 10 人 · 首次发布于 2014 年 5 月 15 日

uPAR-PET/MRI in Glioblastoma Multiforme

计划入组 35 人 · 首次发布于 2016 年 10 月 26 日

UPAR-614

177Lu-uPAR

uPAR-specific CAR T cells

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Veru Inc

United States

Monopar Therapeutics Initiates Phase 1a Trial of uPAR-Targeted Radiopharmaceutical MNPR-101-Lu in Advanced Cancers

FluoGuide Advances Phase II Head and Neck Cancer Trial Following Successful Clinical Results

uPAR-PET Imaging Shows Promise in Predicting Glioma Prognosis